Javier Aznar-rekin lankidetzan egindako argitalpenak (5)

2020

  1. Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 77-85

2019

  1. Phylogeny, resistome, and virulome of escherichia coli causing biliary tract infections

    Journal of Clinical Medicine, Vol. 8, Núm. 12

2018

  1. Heteroresistance to piperacillin-tazobactam in clinical isolates of Escherichia coli sequence type 131

    Antimicrobial Agents and Chemotherapy

2017

  1. Comparison of the in vitro activity of ampicillin and moxifloxacin against listeria monocytogenes at achievable concentrations in the central nervous system

    Journal of Medical Microbiology, Vol. 66, Núm. 6, pp. 713-720

2014

  1. In vitro and intracellular activities of fosfomycin against clinical strains of Listeria monocytogenes

    International Journal of Antimicrobial Agents, Vol. 43, Núm. 2, pp. 135-139